CD274 and neoplasm: To confirm these findings in vivo, we tested the efficacy in the syngeneic mouse B16F10 WT tumor model, which exhibits low to intermediate PD-L1 expression under physiological circumstances depending on factors such as endogenous expression of IFN-γ.